首頁 > 市場調查報告書 > 製藥

疫苗

市場調查報告書

商品編碼

1973176

魯平病疫苗市場規模、佔有率和成長分析：按疫苗類型、最終用戶、通路、配方和地區分類－2026-2033年產業預測

Louping Ill Vaccines Market Size, Share, and Growth Analysis, By Vaccine Type, By End User, By Distribution Channel, By Formulation, By Region - Industry Forecast 2026-2033

出版日期: 2026年02月24日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5個工作天內

價格

簡介目錄

2024年全球環狀肝炎疫苗市值為47億美元，預計2025年將成長至50.6億美元，2033年將成長至91.6億美元。預測期（2026-2033年）的複合年成長率預計為7.7%。

全球環狀腦炎疫苗市場的主要驅動力是持續存在的蜱傳病毒性腦炎風險，這種風險會影響綿羊和山羊，促使農民和公共衛生機構加強疫苗接種力度。該市場涵蓋旨在預防神經系統疾病的獸用生技藥品，這些疾病會降低牲畜生產力並威脅農村經濟。近期進展包括去活化疫苗的改進和在高風險地區加強分發策略，從而提高了公眾意識和監測。監管協調和對獸醫基礎設施的投資進一步降低了疫苗推廣的門檻，並促進了廣泛的免疫接種活動。此外，最尖端科技透過簡化候選疫苗的發現、測試物流和預測分析，提高了疫苗研發效率，從而激發了私營部門的興趣並增強了市場的永續性。

全球環狀病毒病疫苗市場促進因素

全球羊環狀絛蟲病疫苗市場的主要促進因素是牲畜（尤其是綿羊）羊環狀絛蟲病發病率的不斷上升，這提高了農民和獸醫專業人員的認知。隨著人們對該疾病對牲畜生產力和健康造成的經濟影響的認知不斷加深，對有效疫苗的需求也不斷成長。此外，疫苗技術和配方的進步提高了羊環狀絛蟲病疫苗的有效性和安全性，進一步加速了疫苗的推廣應用。同時，政府對農業領域疾病預防的支持和資金投入也顯著促進了該市場的成長，並確保了牲畜健康管理採取積極主動的方式。

全球循環疾病疫苗市場的限制因素

全球環狀絛蟲病疫苗市場的主要阻礙因素是畜牧養殖戶和獸醫對環狀絛蟲病的認知和了解有限。這種知識匱乏會導致疫苗接種率低下，因為許多相關人員低估了疾病的影響或未能認知到接種疫苗的益處。此外，預算限制和其它衛生優先事項可能導致畜牧養殖戶不願投資疫苗，尤其是在他們認為疾病發生率較低的地區。因此，這種情況阻礙了市場成長，並影響了動物健康疾病控制策略的整體有效性。

全球循環疾病疫苗市場趨勢

全球循環疾病疫苗市場正經歷著向「同一健康」一體化舉措的顯著轉變，該計劃強調獸醫服務、公共衛生機構、野生動物管理者和農業社區之間的跨部門合作。這種合作模式共用協調的監測活動和共享的風險評估，促進高風險地區進行有針對性的免疫宣傳活動，從而重新定義了疫苗策略。透過建立信任和共用資源，這些努力使獸醫實踐與通用感染疾病控制和公共衛生優先事項保持一致。動物健康、人類健康和生態學因素的整合正在加速疫苗計畫的部署，推動永續的控制工作，並提高相關人員在循環疾病管理中的參與。

北美洲
- 美國
- 加拿大
歐洲
- 德國
- 西班牙
- 法國
- 英國
- 義大利
- 其他歐洲地區
亞太地區
- 中國
- 印度
- 日本
- 韓國
- 亞太其他地區
拉丁美洲
- 墨西哥
- 巴西
- 其他拉丁美洲地區
中東和非洲
- 海灣合作理事會國家
- 南非
- 其他中東和非洲地區

競爭資訊

前五大公司對比
主要企業的市場定位（2025 年）
主要市場公司採取的策略
近期市場趨勢
企業市佔率分析（2025 年）
主要企業公司簡介
- 公司詳情
- 產品系列分析
- 按細分市場進行企業市佔率分析
- 2023-2025年營收年比比較

主要企業簡介

Zoetis
Merck Animal Health
Ceva Sante Animale
Boehringer Ingelheim Animal Health
Elanco Animal Health
Neogen Corporation
Virbac
Hipra
Synlogic
Aggressopet
Vetoquinol
IDEXX Laboratories
Pharmgate
Kemin Industries
AgriLabs
Biovac
Global Animal Products
Alltech
Vetoquinol
Wuxi Biologics

結論與建議

簡介目錄

Product Code: SQMIG35I2523

Global Louping Ill Vaccines Market size was valued at USD 4.7 Billion in 2024 and is poised to grow from USD 5.06 Billion in 2025 to USD 9.16 Billion by 2033, growing at a CAGR of 7.7% during the forecast period (2026-2033).

The global louping ill vaccines market is primarily driven by the ongoing risk of tick-borne viral encephalitis affecting sheep and goats, prompting a focus on vaccination efforts by farmers and public health entities. This market encompasses veterinary biologics aimed at preventing neurological diseases that can lower flock productivity and jeopardize rural economies. Historical advancements have witnessed the evolution of inactivated vaccines and enhanced distribution strategies in high-risk regions, achieving greater awareness and surveillance. Regulatory harmonization and investments in veterinary infrastructure further lower adoption barriers, facilitating widespread immunization efforts. Additionally, cutting-edge developments in AI promote efficiency in vaccine development by streamlining candidate discovery, trial logistics, and predictive analytics, fostering interest from the private sector and enhancing market sustainability.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Louping Ill Vaccines market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Louping Ill Vaccines Market Segments Analysis

Global louping ill vaccines market is segmented by vaccine type, end user, distribution channel, formulation and region. Based on vaccine type, the market is segmented into Inactivated Vaccines and Live Attenuated Vaccines. Based on end user, the market is segmented into Veterinary Clinics and Research Institutions. Based on distribution channel, the market is segmented into Direct Sales, Online Retail and Distributors. Based on formulation, the market is segmented into Injectable Formulations and Oral Vaccines. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Louping Ill Vaccines Market

A key market driver for the Global Louping Ill Vaccines Market is the increasing incidence of louping ill disease in livestock, particularly sheep, which has raised awareness among farmers and veterinary professionals. The growing understanding of the disease's economic impact on livestock productivity and health is driving the demand for effective vaccination solutions. Additionally, advancements in vaccine technology and formulation are enhancing the efficacy and safety profiles of louping ill vaccines, further boosting their adoption. Furthermore, supportive government initiatives and funding aimed at disease prevention in agriculture are contributing significantly to the growth of this market, ensuring a proactive approach to livestock health management.

Restraints in the Global Louping Ill Vaccines Market

A significant restraint in the global louping ill vaccines market is the limited awareness and understanding of louping ill disease among livestock producers and veterinarians. This lack of knowledge can lead to lower vaccination rates, as many stakeholders may underestimate the disease's impact or fail to recognize the benefits of vaccination. Furthermore, budget constraints and competing health priorities may deter livestock owners from investing in vaccines, especially in regions where the disease is perceived as less prevalent. Consequently, this situation hinders market growth and affects the overall efficacy of disease management strategies in animal health.

Market Trends of the Global Louping Ill Vaccines Market

The Global Louping Ill Vaccines market is witnessing a significant trend towards integrated One Health initiatives that emphasize cross-sector collaboration among veterinary services, public health authorities, wildlife managers, and farming communities. This collaborative approach is redefining vaccination strategies, as coordinated surveillance and shared risk assessments facilitate targeted immunization campaigns in high-risk areas. By fostering trust and resource-sharing, these initiatives align veterinary practices with zoonotic disease management and public health priorities. The integration of animal health with human health and ecological factors is enhancing the adoption of vaccine programs, driving sustainable control efforts, and increasing stakeholder engagement in managing louping ill.

Introduction

Objectives of the Study
Market Definition & Scope

Research Methodology

Research Process
Secondary & Primary Data Methods
Market Size Estimation Methods

Executive Summary

Global Market Outlook
Key Market Highlights
Segmental Overview
Competition Overview

Market Dynamics & Outlook

Macro-Economic Indicators
Drivers & Opportunities
Restraints & Challenges
Supply Side Trends
Demand Side Trends
Porters Analysis & Impact
- Competitive Rivalry
- Threat of Substitute
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Key Success Factors
Market Impacting Factors
Top Investment Pockets
Ecosystem Mapping
Market Attractiveness Index 2025
PESTEL Analysis
Regulatory Landscape

Global Louping Ill Vaccines Market Size by Vaccine Type & CAGR (2026-2033)

Market Overview
Inactivated Vaccines
- Whole Virus Vaccines
- Subunit Vaccines
Live Attenuated Vaccines

Global Louping Ill Vaccines Market Size by End User & CAGR (2026-2033)

Market Overview
Veterinary Clinics
Research Institutions

Global Louping Ill Vaccines Market Size by Distribution Channel & CAGR (2026-2033)

Market Overview
Direct Sales
Online Retail
Distributors

Global Louping Ill Vaccines Market Size by Formulation & CAGR (2026-2033)

Market Overview
Injectable Formulations
Oral Vaccines

Global Louping Ill Vaccines Market Size & CAGR (2026-2033)

North America (Vaccine Type, End User, Distribution Channel, Formulation)
- US
- Canada
Europe (Vaccine Type, End User, Distribution Channel, Formulation)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific (Vaccine Type, End User, Distribution Channel, Formulation)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America (Vaccine Type, End User, Distribution Channel, Formulation)
- Mexico
- Brazil
- Rest of Latin America
Middle East & Africa (Vaccine Type, End User, Distribution Channel, Formulation)
- GCC Countries
- South Africa
- Rest of Middle East & Africa

Competitive Intelligence

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Developments in the Market
Company Market Share Analysis, 2025
Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

Zoetis
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Ceva Sante Animale
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Boehringer Ingelheim Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Elanco Animal Health
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Neogen Corporation
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Virbac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hipra
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Synlogic
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Aggressopet
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
IDEXX Laboratories
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Pharmgate
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Kemin Industries
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
AgriLabs
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biovac
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Global Animal Products
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Alltech
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Vetoquinol
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Wuxi Biologics
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments